SCHEMBL2867170

SCHEMBL2867170

O=C(O)c1ccc2[nH]nc(-c3ccc4ccccc4n3)c2c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITK Q08881 2/20 0.52
MAPK1 P28482 7/20 0.49
MAP2K4 P45985 5/20 0.49
MAPKAPK3 Q16644 3/20 0.49
MAPK6 Q16659 3/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
MAPK3 P27361 2/20 0.43
FLT3 P36888 1/20 0.42
GPBAR1 Q8TDU6 2/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
PAK4 O96013 1/20 0.41
CDK2 P24941 1/20 0.41
CYSLTR1 Q9Y271 2/20 0.40
CYSLTR2 Q9NS75 1/20 0.40
MGAM O43451 1/20 0.40
CHEK1 O14757 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866668 0.86 ALOX15 (0.44) ITKMAPK1MAP2K4NPC1RAB9A
SCHEMBL2855850 0.81 MAP2K4 (0.59) ITKMAPK1MAP2K4MAPKAPK3MAPK6
SCHEMBL2868673 0.80 CHEK1 (0.44) CHEK1
SCHEMBL13198202 0.80 CHEK1 (0.44) CHEK1
SCHEMBL2866791 0.80 MAP2K4 (0.69) ITKMAPK1MAP2K4MAPKAPK3MAPK6
SCHEMBL2861172 0.79 LRRK2 (0.61) ITKMAPK1MAP2K4MAPKAPK3MAPK6
SCHEMBL2859537 0.79 FGFR1 (0.53) ITKMAPK1MAP2K4MAPKAPK3MAPK6
SCHEMBL2867324 0.79 PIM1 (0.56) ITKMAPK1MAP2K4MAPKAPK3MAPK6
SCHEMBL2870415 0.79 CHEK1 (0.45) MAPK1FLT3CHEK1
SCHEMBL29363709 0.78 FGFR1 (0.55) ITKMAP2K4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ITK 3726/4885MAPK1 1/4885MAP2K4 61/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 ITK 3628/4885MAPK1 1/4885MAP2K4 53/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ITK 3726/4885MAPK1 1/4885MAP2K4 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.